Revalorisation of bovine collagen as a potential precursor of angiotensin I-converting enzyme (ACE) inhibitory peptides based on in silico and in vitro protein digestions

Journal of Functional Foods

Volumn 24, Issue , 2016, Pages 196-206

  Fu, Yu ^a   Young, Jette Feveile ^a   Løkke, Mette Marie ^a   Lametsch, René ^b   Aluko, Rotimi E ^c   Therkildsen, Margrethe ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

ACE inhibitory peptides; BIOPEP; Collagen; In silico analysis; QSAR

Indexed keywords

EID: 84963568271     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.03.026     Document Type: Article

References (55)

1. Alderman C.P. Adverse effects of the angiotensin-converting enzyme inhibitors. Annals of Pharmacotherapy 1996, 30:55-61.
2. Altschul S.F., Wootton J.C., Gertz E.M., Agarwala R., Morgulis A., Schaffer A.A., Yu Y.K. Protein database searches using compositionally adjusted substitution matrices. FEBS Journal 2005, 272:5101-5109.
3. Aluko R.E. Antihypertensive peptides from food proteins. Annual Review of Food Science and Technology 2015, 6:235-262.
4. Aluko R.E. Structure and function of plant protein-derived antihypertensive peptides. Current Opinion in Food Science 2015, 4:44-50.
5. Arihara K., Nakashima Y., Mukai T., Ishikawa S., Itoh M. Peptide inhibitors for angiotensin I-converting enzyme from enzymatic hydrolysates of porcine skeletal muscle proteins. Meat Science 2001, 57:319-324.
6. Byers P.H., Click E.M., Harper E., Bornstein P. Interchain disulfide bonds in procollagen are located in a large nontriple-helical COOH-terminal domain. Proceedings of the National Academy of Sciences 1975, 72:3009-3013.
7. Byun H.G., Kim S.K. Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process Biochemistry 2001, 36:1155-1162.
8. Cavazos A., Gonzalez de Mejia E. Identification of bioactive peptides from cereal storage proteins and their potential role in prevention of chronic diseases. Comprehensive Reviews in Food Science and Food Safety 2013, 12:364-380.
9. Chang Y.-W., Alli I. In silico assessment: Suggested homology of chickpea (Cicer arietinum L.) legumin and prediction of ACE-inhibitory peptides from chickpea proteins using BLAST and BIOPEP analyses. Food Research International 2012, 49:477-486.
10. Cheung I.W.Y., Nakayama S., Hsu M.N.K., Samaranayaka A.G.P., Li-Chan E.C.Y. Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (Avena sativa) proteins by in silico and in vitro analyses. Journal of Agricultural and Food Chemistry 2009, 57:9234-9242.
11. Damgaard T., Lametsch R., Otte J. Antioxidant capacity of hydrolyzed animal by-products and relation to amino acid composition and peptide size distribution. Journal of Food Science and Technology 2015, 52:6511-6519.
12. Efron B., Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. The American Statistician 1983, 37:36-48.
13. Ewart H.S., Dennis D., Potvin M., Tiller C., Fang L.H., Zhang R., Zhu X.M., Curtis J.M., Cloutier S., Du G.H., Barrow C.J. Development of a salmon protein hydrolysate that lowers blood pressure. European Food Research and Technology 2009, 229:561-569.
14. Fu Y., Young J.F., Dalsgaard T.K., Therkildsen M. Separation of angiotensin I-converting enzyme inhibitory peptides from bovine connective tissue and their stability towards temperature, pH and digestive enzymes. International Journal of Food Science and Technology 2015, 50:1234-1243.
15. Fu Y., Zhao X.-H. In vitro responses of hFOB1.19 cells towards chum salmon (Oncorhynchus keta) skin gelatin hydrolysates in cell proliferation, cycle progression and apoptosis. Journal of Functional Foods 2013, 5:279-288.
16. Gelse K., Poschl E., Aigner T. Collagens - Structure, function, and biosynthesis. Advanced Drug Delivery Reviews 2003, 55:1531-1546.
17. Gómez-Guillén M.C., Giménez B., López-Caballero M.E., Montero M.P. Functional and bioactive properties of collagen and gelatin from alternative sources: A review. Food Hydrocolloids 2011, 25:1813-1827.
18. Gu Y., Wu J. LC-MS/MS coupled with QSAR modeling in characterising of angiotensin I-converting enzyme inhibitory peptides from soybean proteins. Food Chemistry 2013, 141:2682-2690.
19. Gupta S., Kapoor P., Chaudhary K., Gautam A., Kumar R., Raghava G.P., Consortium O.S.D.D. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE 2013, 8:e73957.
20. Ibrahim M.M., Damasceno A. Hypertension in developing countries. The Lancet 2012, 380:611-619.
21. Iwaniak A., Dziuba J. BIOPEP-PBIL tool for the analysis of the structure of biologically active motifs derived from food proteins. Food Technology and Biotechnology 2011, 49:118-127.
22. Iwaniak A., Minkiewicz P., Darewicz M. Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction. Comprehensive Reviews in Food Science and Food Safety 2014, 13:114-134.
23. Iwaniak A., Minkiewicz P., Darewicz M., Protasiewicz M., Mogut D. Chemometrics and cheminformatics in the analysis of biologically active peptides from food sources. Journal of Functional Foods 2015, 16:334-351.
24. Je J.-Y., Cho Y.-S., Gong M., Udenigwe C.C. Dipeptide Phe-Cys derived from in silico thermolysin-hydrolysed RuBisCO large subunit suppresses oxidative stress in cultured human hepatocytes. Food Chemistry 2015, 171:287-291.
25. Kim D.W., Park K., Ha G., Jung J.R., Chang O., Ham J.-S., Jeong S.-G., Park B.-Y., Song J., Jang A. Anti-oxidative and neuroprotective activities of pig skin gelatin hydrolysates. Korean Journal for Food Science of Animal Resources 2013, 33:258-267.
26. Kim S.K., Byun H.G., Park P.J., Shahidi F. Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. Journal of Agricultural and Food Chemistry 2001, 49:2992-2997.
27. Lacroix I.M.E., Li-Chan E.C.Y. Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. Journal of Functional Foods 2012, 4:403-422.
28. Lafarga T., Hayes M. Bioactive peptides from meat muscle and by-products: Generation, functionality and application as functional ingredients. Meat Science 2014, 98:227-239.
29. Lafarga T., O'Connor P., Hayes M. Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis. Peptides 2014, 59:53-62.
30. Lau C., Abdullah N., Shuib A. Novel angiotensin I-converting enzyme inhibitory peptides derived from an edible mushroom, Pleurotus cystidiosus O.K. Miller identified by LC-MS/MS. BMC Complementary and Alternative Medicine 2013, 13:313.
31. Majumder K., Wu J. A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics. Food Research International 2010, 43:1371-1378.
32. Marczak E.D., Usui H., Fujita H., Yang Y., Yokoo M., Lipkowski A.W., Yoshikawa M. New antihypertensive peptides isolated from rapeseed. Peptides 2003, 24:791-798.
33. Matsumura N., Fujii M., Takeda Y., Sugita K., Shimizu T. Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosciences Biotechnology and Biochemistry 1993, 57:695-697.
34. Matthews D.M., Adibi S.A. Peptide absorption. Gastroenterology 1976, 71:151-161.
35. Miguel M., Aleixandre M.A., Ramos M., López-Fandiño R. Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. Journal of Agricultural and Food Chemistry 2006, 54:726-731.
36. Minkiewicz P., Dziuba J., Iwaniak A., Dziuba M., Darewicz M. BIOPEP database and other programs for processing bioactive peptide sequences. Journal of AOAC International 2008, 91:965-980.
37. Minkiewicz P., Dziuba J., Michalska J. Bovine meat proteins as potential precursors of biologically active peptides - A computational study based on the BIOPEP database. Food Science and Technology International 2011, 17:39-45.
38. Nakashima Y., Arihara K., Sasaki A., Mio H., Ishikawa S., Itoh M. Antihypertensive activities of peptides derived from porcine skeletal muscle myosin in spontaneously hypertensive rats. Journal of Food Science 2002, 67:434-437.
39. Ondetti M.A., Cushman D.W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 1977, 196:441-444.
40. Otte J., Shalaby S.M., Zakora M., Nielsen M.S. Fractionation and identification of ACE-inhibitory peptides from α-lactalbumin and β-casein produced by thermolysin-catalysed hydrolysis. International Dairy Journal 2007, 17:1460-1472.
41. Petrat-Melin B., Andersen P., Rasmussen J.T., Poulsen N.A., Larsen L.B., Young J.F. In vitro digestion of purified β-casein variants A1, A2, B, and I: Effects on antioxidant and angiotensin-converting enzyme inhibitory capacity. Journal of Dairy Science 2015, 98:15-26.
42. Pripp A.H., Isaksson T., Stepaniak L., Sørhaug T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. European Food Research and Technology 2004, 219:579-583.
43. Saiga A., Iwai K., Hayakawa T., Takahata Y., Kitamura S., Nishimura T., Morimatsu F. Angiotensin I-converting enzyme-inhibitory peptides obtained from chicken collagen hydrolysate. Journal of Agricultural and Food Chemistry 2008, 56:9586-9591.
44. Saito Y., Kawato A., Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosciences Biotechnology and Biochemistry 1994, 58:1767-1771.
45. Sandberg M., Eriksson L., Jonsson J., Sjöström M., Wold S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. Journal of Medicinal Chemistry 1998, 41:2481-2491.
46. Siebert K.J. Modeling protein functional properties from amino acid composition. Journal of Agricultural and Food Chemistry 2003, 51:7792-7797.
47. Skeggs L.T., Kahn J.R., Shumway N.P. The preparation and function of the hypertensin-converting enzyme. The Journal of Experimental Medicine 1956, 103:295-299.
48. Toldrá F., Aristoy M.C., Mora L., Reig M. Innovations in value-addition of edible meat by-products. Meat Science 2012, 92:290-296.
49. Udenigwe C.C. Bioinformatics approaches, prospects and challenges of food bioactive peptide research. Trends in Food Science & Technology 2014, 36:137-143.
50. Udenigwe C.C., Aluko R.E. Food protein-derived bioactive peptides: Production, processing, and potential health benefits. Journal of Food Science 2012, 77:R11-R24.
51. Udenigwe C.C., Gong M., Wu S. In silico analysis of the large and small subunits of cereal RuBisCO as precursors of cryptic bioactive peptides. Process Biochemistry 2013, 48:1794-1799.
52. Udenigwe C.C., Howard A. Meat proteome as source of functional biopeptides. Food Research International 2013, 54:1021-1032.
53. Vercruysse L., Smagghe G., van der Bent A., van Amerongen A., Ongenaert M., Van Camp J. Critical evaluation of the use of bioinformatics as a theoretical tool to find high-potential sources of ACE inhibitory peptides. Peptides 2009, 30:575-582.
54. Wold S., Sjostrom M., Eriksson L. PLS-regression: A basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems 2001, 58:109-130.
55. Wu J.P., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di- and tripeptides. Journal of Agricultural and Food Chemistry 2006, 54:732-738.